Reliable Conjugation Technology for Precision Medicine
  • Home
  • The Technology
    • Versatile Platform
    • Groundbreaking Technology
    • Strong Science
  • Management
    • Scientific Founders
    • Board of Directors
    • Scientific Advisory Board
  • News
  • Contact us
  • More
    • Home
    • The Technology
      • Versatile Platform
      • Groundbreaking Technology
      • Strong Science
    • Management
      • Scientific Founders
      • Board of Directors
      • Scientific Advisory Board
    • News
    • Contact us
Reliable Conjugation Technology for Precision Medicine
  • Home
  • The Technology
    • Versatile Platform
    • Groundbreaking Technology
    • Strong Science
  • Management
    • Scientific Founders
    • Board of Directors
    • Scientific Advisory Board
  • News
  • Contact us

SINGZYME

SINGZYMESINGZYMESINGZYME

Reliable, fast and flexible technology for developing a wide range of Bio-conjugates

Contact Us
Learn More

About Us

Our Mission

  

Singzyme’s mission is to deliver on the promise of effective immuno-therapies by developing safer and more homogenous, precision medicines for the well-being of patients worldwide.

Backed by our first-in-class bioconjugation platform, we support the global pharmaceutical industries with their Research and Development (R&D) endeavours to allow promising therapeutics to reach the patient bedside as fast as possible at the best cost.

Innovative Technology

 The core technology of the platform lies in the use of Peptide Asparaginyl Ligases (PALs) to conjugate active drugs or any other payloads to proteins.

Singzyme's platform for antibodies and nanobodies engineering and conjugation provides a one- stop solution to the problems faced by Antibody Drug Conjugates developers, stemming from their manufacturing process. Singzyme provides an integrated, high-speed, precision bio-manufacturing platform for ADCs and other bioconjugates.

Learn more

Applications

  1. Cancer immunotherapy: faster production of antibody-drug-conjugates with minimal footprint on the final product and the possibility to attach several payloads
  2. Imaging for disease diagnosis: production of radiopharmaceuticals for PET scan imaging (Nanobodies or mAbs) with minimal radioactive waste due to the highest conjugation efficiency.

Learn more

Copyright © 2022 Singzyme

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept